GSK-3β is a putative target of Li, to which its inhibition and its downstream proteins, including reduction of both tau protein phosphorylation and amyloid-β42 production, was associated with the neuroprotective effect of Li reducing the risk of neurodegenerative diseases such as AD in subjects with bipolar disorder (38). This evidence concerns the gene GSK3B and bipolar disorder.